Episode 347: ESMO 2024 - DV + Pembro in Urothelial Cancer

The Uromigos - Un pódcast de The Uromigos

Matt Galsky describes his ESMO 2024 abstract of disitimab vedotiin + pembrlizumab in bladder cancer